mr. francois potus degrees recognitionsdeptmed.queensu.ca/assets/research/archer research/francois...

9

Click here to load reader

Upload: lamthien

Post on 15-Sep-2018

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Mr. Francois Potus Degrees Recognitionsdeptmed.queensu.ca/assets/Research/Archer Research/Francois Potus... · DRAFT Mr. Francois Potus 1 This is a draft version only. Do not submit

DRAFTMr. Francois Potus

1

This is a draft version only. Do not submit to any funding organization. Only thefinal version from the History page can be submitted.

Protected when completed

Mr. Francois Potus

Degrees

2012/2 - 2017/11 Doctorate, doctorate in science, Université LavalDegree Status: Completed

2009/9 - 2012/6 Master's Thesis, masters of science, Université Lyon I - Claude BernardDegree Status: Completed

2007/9 - 2009/6 Bachelor's, bachelor in science, Université Clermont-Ferrand II (B. Pascal)Degree Status: Completed

Recognitions

2106/6 short term training competitionFonds de recherche du Québec - Santé (FRQS)

2017/7 peer reviewer in Advances in Medical SciencesAdvances in Medical Sciences

2017/4 Peer reviewer for Journal of Molecular medicineJournal of molecular medecine

2016/11 3cpr junior investigator travel stipendAmerican heart association

2016/6 Peer reviewer for European Respiratory Journal (ERJ)European respiratory journal

Employment

2017/11 postdoctoral Fellowshipmedicine, medicine, Queen's University at Kingston

2012/2 - 2017/11 PhD's scholarshipmedecine, université Laval, Université Laval

2010/9 - 2011/6 Master's scholarshipUMR 5242, ENS de Lyon, CNRS-INSERM pharmacologie-endocrinologie

2010/5 - 2010/7 Master's scholarshipCNRS UMR 5242, ENS de Lyon, CNRS-INSERM pharmacologie-endocrinologie

2009/6 - 2009/8 Bachelor's internship.biochemistry, pathology, university Blaise pascal Clermont Ferrand, Centre HospitalierRégional de Roanne

Page 2: Mr. Francois Potus Degrees Recognitionsdeptmed.queensu.ca/assets/Research/Archer Research/Francois Potus... · DRAFT Mr. Francois Potus 1 This is a draft version only. Do not submit

DRAFTMr. Francois Potus

2

2008/6 - 2008/8 Bachelor's internship.Biochemistry, pathology and microbiology, university Blaise pascal Clermont Ferrand,Centre Hospitalier Régional de Roanne

AffiliationsThe primary affiliation is denoted by (*)

(*) 2017/1 Postdoctoral fellow, medecine, Queen's University at Kingston

Publications

Journal Articles

1. Potus F, Ruffenach G, Dahou A, Thebault C, Breuils-Bonnet S, Tremblay È, Nadeau V, Paradis R, GraydonC, Wong R, Johnson I, Paulin R, Lajoie AC, Perron J, Charbonneau E, Joubert P, Pibarot P, Michelakis ED,Provencher S, Bonnet S.(2105). Downregulation of miR-126 Contributes to the Failing Right Ventricle inPulmonary Arterial Hypertension.Circulation. 136(10): 932-943.PublishedRefereed?: Yes

2. Nadeau V, Potus F, Boucherat O, Paradis R, Tremblay E, Iglarz M, Paulin R, Bonnet S, ProvencherS.(2018). EXPRESS: Dual eta/etb blockade with macitentan improves both vascular remodelling andangiogenesis in pulmonary arterial hypertension.Pulmonary Circulation. 10: 00-00.Refereed?: Yes

3. Ping Yu Xiong, Francois Potus, Winnie Chan, Stephen L. Archer. (2018). Models and MolecularMechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension. Hypertension. 71: 00-00.Refereed?: Yes

4. Meloche J, Lampron MC, Nadeau V, Maltais M, Potus F, Lambert C, Tremblay E, Vitry G, Breuils-Bonnet S, Boucherat O, Charbonneau E, Provencher S, Paulin R, Bonnet S.(2017). Implication ofInflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary ArterialHypertension.Arteriosclerosis, Thrombosis, and Vascular Biology. 37(9): 156-165.PublishedRefereed?: Yes

5. Boucherat O, Chabot S, Paulin R, Trinh I, Bourgeois A, Potus F, Lampron MC, Lambert C, Breuils-BonnetS, Nadeau V, Paradis R, Goncharova EA, Provencher S, Bonnet S.(2017). HDAC6: A Novel HistoneDeacetylase Implicated in Pulmonary Arterial Hypertension.Scientific Reports. 7(1): 4546-4560.PublishedRefereed?: Yes

6. F. Antigny, A. Hautefort, J. Meloche, M. Belacel-Ouari, B. Manoury, C. Rucker-Martin, C. Péchoux, F.Potus, V. Nadeau, E. Tremblay, G. Ruffenach, A. Bourgeois, P. Dorfmüller, S. Breuils-Bonnet, E. Fadel,B. Ranchoux, P. Jourdon, B. Girerd, D. Montani, S. Provencher, S. Bonnet, G. Simonneau, M. Humbert,F. Perros.(2016). Potassium-ChannelSubfamily K-Member 3 (KCNK3) Contributes to the Development ofPulmonaryArterial Hypertension. Circulation. 133(14): 1371-1385.PublishedRefereed?: Yes

Page 3: Mr. Francois Potus Degrees Recognitionsdeptmed.queensu.ca/assets/Research/Archer Research/Francois Potus... · DRAFT Mr. Francois Potus 1 This is a draft version only. Do not submit

DRAFTMr. Francois Potus

3

7. Hong Z, Chen KH, DasGupta A, Potus F, Dunham-Snary K, Bonnet S, Tian L, Fu J, Breuils-Bonnet S,Provencher S, Wu D, Mewburn J, Ormiston ML, Archer SL.(2016). MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.Am. J. Respir. Crit. Care Med. 195(4): 515-529.PublishedRefereed?: Yes

8. Ruffenach G, Chabot S, Tanguay VF, Courboulin A, Boucherat O, Potus F, Meloche J, Pflieger A, Breuils-Bonnet S, Nadeau V, Paradis R, Tremblay E, Girerd B, Hautefort A, Montani D, Fadel E, Dorfmuller P,Humbert M, Perros F, Paulin R, Provencher S, Bonnet S.(2016). Role for RUNX2 in proliferative andcalcified vascular lesions seen in pulmonary arterial hypertension. Am J Respir Crit Care Med. 194(10):1273-1285.PublishedRefereed?: Yes

9. Malenfant S, Potus F, Mainguy V, Leblanc È, Malenfant M, Ribeiro F, Saey D, Maltais F, Bonnet S,Provencher S.(2015). Impaired Skeletal Muscle Oxygenation and Exercise Tolerance in PulmonaryHypertension.Medicine and science in sports and exercise. 47(11): 2273-2282.PublishedRefereed?: Yes

10. Meloche J*, Potus F*, Vaillancourt M, Bourgeois A, Johnson IH, Deschamps L, Chabot S, Ruffenach GN,Henry S, Breuils-Bonnet S, Tremblay È, Nadeau V, Lambert CM, Paradis R, Provencher S, Bonnet S. *J.M.and F.P. contributed equally to the study.(2015). Bromodomain Containing Protein-4: The Epigenetic Originof Pulmonary Arterial Hypertension.Circulation Research. 117(6): 525-535.PublishedRefereed?: Yes

11. Meloche J, Le Guen M, Potus F, Vinck J, Ranchoux B, Johnson I, Antigny F, Tremblay E, Breuils-Bonnet S, Perros F, Provencher S, Bonnet S.(2015). MiR-223 Reverses Experimental Pulmonary ArterialHypertension.American Journal of Physiology. Cell Physiology. 309(6): 363-372.PublishedRefereed?: Yes

12. Francois Potus, Marie LeGuen, Steeve Provencher, Jolyane Meloche, Sebastien Bonnet. (2015). DNAdamage at the dawn of micro-RNA impairment in pulmonary arterial hypertension.RNA & DISEASE. 2(4):810-822.PublishedRefereed?: No

13. F. Potus, C. Graydon, S. Provencher, S. Bonnet.(2014). Vascular remodeling process in pulmonary arterialhypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series).Pulmonary Circulation.4(2): 175-184.PublishedRefereed?: Yes

14. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay È, Breuils-Bonnet S, Ribeiro F, Porlier A, MaltaisF, Bonnet S, Provencher S.(2014). Impaired angiogenesis and peripheral muscle microcirculation losscontribute to exercise intolerance in pulmonary arterial hypertension.American Journal of Respiratory andCritical Care Medicine. 190(3): 218-228.PublishedRefereed?: Yes

15. Sharma S, Umar S, Potus F, Iorga A, Wong G, Meriwether D, Breuils-Bonnet S, Mai D, Navab K, Ross D,Navab M, Provencher S, Fogelman AM, Bonnet S, Reddy ST, Eghbali M.(2014). Apolipoprotein A-I mimeticpeptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p.Circulation. 130(9): 776-785.PublishedRefereed?: Yes

Page 4: Mr. Francois Potus Degrees Recognitionsdeptmed.queensu.ca/assets/Research/Archer Research/Francois Potus... · DRAFT Mr. Francois Potus 1 This is a draft version only. Do not submit

DRAFTMr. Francois Potus

4

16. Malenfant S*, Potus F*, Fournier F, Breuils-Bonnet S, Pflieger A, Bourassa S, Tremblay È, Nehmé B,Droit A, Bonnet S, Provencher S. * Simon Malenfant and François Potus contributed equally to this work.(2014). Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension.Journalof medical medecine. 93(5): 573-584.PublishedRefereed?: Yes

17. Meloche J, Pflieger A, Vaillancourt M, Paulin R, Potus F, Zervopoulos S, Graydon C, Courboulin A, Breuils-Bonnet S, Tremblay E, Couture C, Michelakis ED, Provencher S, Bonnet S.(2013). Role for DNA damagesignaling in pulmonary arterial hypertension.Circulation. 309(6): 786-797.PublishedRefereed?: Yes

18. S. Malenfant, A.S. Neyron, R. Paulin, F. Potus, S. Provencher, S. Bonnet. (2013). Signal transduction in thedevelopment of pulmonary arterial hypertension. Pulmonary circulation. 3(2): 278-293.PublishedRefereed?: Yes

Book Chapters

1. Olivier Boucherat; François Potus; and Sébastien Bonnet.(2015). MicroRNA and pulmonary hypertension.springer. microRNA: from molecular biology to clinical practice. : 237-252.Accepted, Advances in Experimental Medicine and Biology, Germany

Conference Publications

1. Guillaume Margaillan , Audrey Courboulin , Francois Potus , Anthony Courchesne , Christian Couture ,Pierre Bonnet , Steeve Provencher , Sebastien Bonnet ,. RUNX2 Regulates The Normoxic Activation OfThe Hypoxic Inducible Factor (HIF-1) Under The Influence Of MiR-204 In Pulmonary Arterial Hypertension.American Thoracic Society,Abstract

2. Potus F1, Ruffenach G1, Dahou A1, Thebault C1, Breuils-Bonnet S1, Tremblay È1, Nadeau V1, ParadisR1, Graydon C1, Wong R1, Johnson I1, Paulin R1, Lajoie AC1, Perron J1, Charbonneau E1, JoubertP1, Pibarot P1, Michelakis ED1, Provencher S2, Bonnet S2.mir-126 contribute to angiogenesis defect inpulmonary arterial hypertension right ventricle failure. european respiratory society,Abstract

3. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay È, Breuils-Bonnet S, Ribeiro F, Porlier A, MaltaisF, Bonnet S, Provencher S.Skeletal muscle angiomir defects and exercise intolerance in pulmonary arterialhypertension. Canadian respiratory society,Abstract

4. Francois Potus , Sandra Breuils-Bonnet , Simon Malenfant , Steeve Provencher , , Sebastien Bonnet ,.Systemic Microcirculation Impairment Is Associated With Exercise Intolerance In Pulmonary ArterialHypertension. American Thoracic Society,Abstract

5. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay È, Breuils-Bonnet S, Ribeiro F, Porlier A,Maltais F, Bonnet S, Provencher S.Role for miR-126 in exercise intolerance seen in pulmonary arterialhypertension. Canadian respiratory society,Abstract

Page 5: Mr. Francois Potus Degrees Recognitionsdeptmed.queensu.ca/assets/Research/Archer Research/Francois Potus... · DRAFT Mr. Francois Potus 1 This is a draft version only. Do not submit

DRAFTMr. Francois Potus

5

6. Simon Malenfant & François Potus & Frédéric Fournier & Sandra Breuils-Bonnet & Aude Pflieger & SylvieBourassa & Ève Tremblay & Benjamin Nehmé & Arnaud Droit & Sébastien Bonnet & Steeve Provencher.Skeletal muscle impairment and proteomic profil in human pulmonary arterial hypertension. europeanrespiratory society,Abstract

7. Francois Potus , Sandra Breuils-Bonnet , Simon Malenfant , Sebastien Bonnet , Steeve Provencher ,.Muscle Proteomic Signature Of Exercise Intolerance In Pulmonary Arterial Hypertension. AmericanThoracic Society,Abstract

8. Francois Potus , , Colin Graydon , Sandra Breuils-Bonnet , Roxane Paulin , Evangelos D. Michelakis ,Steeve Provencher , Sebastien Bonnet ,. Angiogenesis Defect In Pulmonary Arterial Hypertension RightVentricle Failure: Role Of Small Non-Coding RNA. American Thoracic Society,Abstract

9. Audrey Courboulin , Jolyane Meloche , Francois Potus , Guillaume Margaillan , Steeve Provencher ,Sebastien Bonnet ,. Role For DNA Repair Machinery In Pulmonary Arterial Hypertension. AmericanThoracic Society,Abstract

10. Aude Pflieger, François Potus, Simon Malenfant, Sandra Breuils-Bonnet, Sebastien Bonnet, SteeveProvencher. Abstract 18124: Skeletal Muscle Proteomic Signature in Pulmonary Arterial Hypertension.American Heart Association,Abstract

11. Potus F1, Ruffenach G1, Dahou A1, Thebault C1, Breuils-Bonnet S1, Tremblay È1, Nadeau V1, ParadisR1, Graydon C1, Wong R1, Johnson I1, Paulin R1, Lajoie AC1, Perron J1, Charbonneau E1, JoubertP1, Pibarot P1, Michelakis ED1, Provencher S2, Bonnet S2.Abstract 13396: Downregulation of theAngiomir-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. American HeartAssociation,Abstract

12. Potus F1, Ruffenach G1, Dahou A1, Thebault C1, Breuils-Bonnet S1, Tremblay È1, Nadeau V1, ParadisR1, Graydon C1, Wong R1, Johnson I1, Paulin R1, Lajoie AC1, Perron J1, Charbonneau E1, Joubert P1,Pibarot P1, Michelakis ED1, Provencher S2, Bonnet S2.MiR-126 Down-Regulation: A Specific Signature OfRight Ventricle Failure In PAH. American Thoracic Society,Abstract

13. Potus F1, Ruffenach G1, Dahou A1, Thebault C1, Breuils-Bonnet S1, Tremblay È1, Nadeau V1, ParadisR1, Graydon C1, Wong R1, Johnson I1, Paulin R1, Lajoie AC1, Perron J1, Charbonneau E1, Joubert P1,Pibarot P1, Michelakis ED1, Provencher S2, Bonnet S2.Epigenetic Signature Of Angiogenesis DysfunctionIn Human Right Ventricular Failure Seen In Pulmonary Arterial Hypertension. American Thoracic Society,Abstract

14. Jerome Vinck , , Gregoire Ruffenach , Francois Potus , Sandra Breuils-bonnet , Steeve Provencher ,Sebastien Bonnet ,. MiR-223 A New Signalling Hub Accounting For DNA Damage Signalling And STAT3Activation In Pulmonary Arterial Hypertension. American Thoracic Society,Abstract

15. Gregoire Ruffenach , Virginie Tanguay , Francois Potus , Valérie Nadeau , Steeve Provencher , , SebastienBonnet ,. RunX2 And Calcification Lesions In Experimental And Human Pulmonary Arterial Hypertension.American Thoracic Society,Abstract

16. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay È, Breuils-Bonnet S, Ribeiro F, Porlier A, MaltaisF, Bonnet S, Provencher S.MiR-126, Angiogenesis And Exercise Intolerance In Pulmonary ArterialHypertension. American Thoracic Society,Abstract

Page 6: Mr. Francois Potus Degrees Recognitionsdeptmed.queensu.ca/assets/Research/Archer Research/Francois Potus... · DRAFT Mr. Francois Potus 1 This is a draft version only. Do not submit

DRAFTMr. Francois Potus

6

17. Aude Pflieger , , Francois Potus , Simon Malenfant , Sandra Breuils-Bonnet , Steeve Provencher ,Sebastien Bonnet. Skeletal Muscle Metabolism Defect In Human Pulmonary Arterial Hypertension.American thoracic Society,Abstract

18. Potus F1, Ruffenach G1, Dahou A1, Thebault C1, Breuils-Bonnet S1, Tremblay È1, Nadeau V1, ParadisR1, Graydon C1, Wong R1, Johnson I1, Paulin R1, Lajoie AC1, Perron J1, Charbonneau E1, Joubert P1,Pibarot P1, Michelakis ED1, Provencher S2, Bonnet S2.Downregulation Of The AngiomiR-126 ContributesTo The Failing Right Ventricle In Pulmonary Arterial Hypertension. American Thoracic Society,Abstract

19. Salil Sharma, Francois Potus, Soban Umar, Sandra Breuils-Bonnet, Steeve Provencher, Srinivasa TReddy, Sébastien Bonnet, Mansoureh Eghbali. Abstract 13579: MiR-193-3p is Regulated by 4F viaRetinoid X Receptor Alpha (RXR-α) and Its Gain Attenuates Proliferation of Pulmonary Artery SmoothMuscle Cells From Pulmonary Arterial Hypertension Patients. American Heart Association,Abstract

20. imon Malenfant BSc1,Vincent Mainguy MSc1, François Potus MSc1, Anne-Sophie Neyron BSc1, FrançoisMaltais MD1, Sébastien Bonnet PhD1, Didier Saey PhD1 and Steeve Provencher MD MSc1. AbnormalPeripheral Muscle Oxygenation During Submaximal Exercise In Pulmonary Arterial Hypertension. AmericanThoracic Society,Abstract

21. Gregoire Ruffenach , Sophie Chabot , Francois Potus , , Virginie Tanguay , Mylène Vaillancourt , EveTremblay , Sandra Breuils-Bonnet , Steeve Provencher , Sebastien Bonnet ,. The MiR-204/RUNX2/HDAC6Axis Contributes To HIF-1 Activation In Pulmonary Arterial Hypertension. American Thoracic Society,Abstract

22. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay È, Breuils-Bonnet S, Ribeiro F, Porlier A, MaltaisF, Bonnet S, Provencher S.miR-126; link between angiogenesis and exercise intolerance in pulmonaryarterial hypertension. european respiratory society,Abstract

23. Simon Malenfant, François Potus, Vincent Mainguy, Anne-Sophie Neyron, Evelyn Leblanc, MathieuMalenfant, ève Tremblay, Sandra Breuils-Bonnet, François Maltais, Didier Saey, Sébastien Bonnet, SteeveProvencher. Abstract 16687: Abnormal Peripheral Muscle Oxygenation During Submaximal ExerciseContributes to Exercise Intolerance in Pulmonary Arterial Hypertension. American Heart Association,Abstract

24. Porlier A; Dubé A; Potus F; Bonnet S; Debigaré R; Maltais F.Expression Of MiR-204 In The VastusLateralis Of Patients With Chronic Obstructive Pulmonary Disease. American Thoracic Society,Abstract

25. Francois Potus1, Colin Graydon1, Sandra Breuils Bonnet1, Roxane Paulin2, Evangelos Michelakis2,Steeve Provencher1 and sebastien Bonnet1. Mir-126 dependent alteration of angiogenesis contributes toright ventricle failure in pulmonary arterial hypertension. Experimental Biology,Abstract

26. François Potus, Benoit Ranchoux, Eve Tremblay, Steeve Provencher and Sébastien Bonnet.Developmentof new pre-clinical model ofpulmonary hypertension associated with left heart disease.PVRI,Abstract

27. Valerie Nadeau, Jolyane Meloche, Eve Tremblay, Marie-Claude Lampron, Francois Potus, OlivierBoucherat, Roxane Paulin, Eric Charbonneau, Steeve Provencher, Sebastien Bonnet. Abstract 17140:Altered Epigenetic Signaling in the Coronary Arteries of Patients With Pulmonary Arterial Hypertension: theRole for BRD4 in the Development of Comorbidities. International meeting go american heart association,Abstract

Page 7: Mr. Francois Potus Degrees Recognitionsdeptmed.queensu.ca/assets/Research/Archer Research/Francois Potus... · DRAFT Mr. Francois Potus 1 This is a draft version only. Do not submit

DRAFTMr. Francois Potus

7

28. Andrea Frump , Margie Albrecht , Sandra Breulis Bonnet , François Potus , Steeve Provencher , SébastienBonnet , Mary Beth Brown , Tim Lahm ,. A Cardioprotective Estrogen Receptor α-Apelin Axis MediatesSalutaryEffects of 17β-Estradiol (E2) on Right Ventricular Function in PulmonaryHypertension. Americanthoracic society International Conference,Abstract

29. Rui Adao , Pedro Mendes-Ferreira , Diana Santos-Ribeiro , Carolina Maia-Rocha , François Potus , SandraBreuils-Bonnet , Steeve Provencher , Sébastien Bonnet , Adelino Leite-Moreira , Carmen Brás-Silva ,.Urocortin-2 Improves Right Ventricular Function in Pulmonary ArterialHypertension.American thoracicsociety International Conference,Abstract

30. Antigny F1, Hautefort A2, Meloche J2, Belacel-Ouari M2, Manoury B2, Rucker-Martin C2, Péchoux C2,Potus F2, Nadeau V2, Tremblay E2, Ruffenach G2, Bourgeois A2, Dorfmüller P2, Breuils-Bonnet S2,Fadel E2, Ranchoux B2, Jourdon P2, Girerd B2, Montani D2, Provencher S2, Bonnet S2, SimonneauG2, Humbert M2, Perros F2.Potassium Channel Subfamily K Member 3 (KCNK3) Contributes totheDevelopment of Pulmonary Arterial Hypertension.American thoracic society International Conference,Abstract

31. Valerie Nadeau , Sébastien Bonnet , Renée Paradis , François Potus , Eve Tremblay , Caroline Lambert ,Marc Iglarz , Steeve Provencher ,. Pulmonary Arterial Hypertension Improvement by Macitentan isAssociatedwith an Increase in Right Ventricle, Peripheral Muscle and Lungs Angiogenesis.Americanthoracic society International Conference,Abstract

32. Jolyane Meloche , Valerie Nadeau , Eve Tremblay , François Potus , Sophie Chabot , Eric Charbonneau ,Steeve Provencher , Sébastien Bonnet ,. The Lung Origin of Coronary Artery Diseases in PulmonaryHypertensionPatients: Role for the DNA damage/BRD4 Axis. American thoracic society InternationalConference,Abstract

33. Pedro Mendes-Ferreira , François Potus , Diana Santos-Ribeiro , Carolina Maia-Rocha , Rui Adao , AdelinoLeite-Moreira , Steeve Provencher , Sébastien Bonnet , Carmen Brás-Silva ,. MicroRNA-146a ExpressionIs Increased in Human PAH. American thoracic society International Conference,Abstract

34. François Potus, Olivier Boucherat, Sophie Chabot, Alice Bourgeois, Caroline Lambert, Sandra Breuils-Bonnet, Renée Paradis, Steeve Provencher and Sébastien Bonnet. Abstract 19388: HDAC6 InhibitionPotential in Pulmonary Arterial Hypertension. International conference of American Heart Association,Abstract

35. François Potus1, Frédéric Perros1, Sébastien Bonnet1 and Steeve Provencher1.Crizotinib exacerbatespulmonary arterial hypertension throughmacrophage activation. American Heart Association,Abstract

36. Potus F; Ranchoux B; Provencher S; Bonnet S.Metabolic syndrome induced by olanzapine potentiatepulmonary hypertension and pulmonary vascular remodelling in the rat supra-aortic banding model.American Heart Association,Abstract

37. Aude Pflieger1, François Potus1, Simon Malenfant1, Sandra Breuils-Bonnet1, Sebastien Bonnet1 andSteeve Provencher1. Skeletal muscle proteomic signature in pulmonary arterial hypertension. ExperimentalBiology,Abstract

38. Grégoire Ruffenach1, Sophie Chabot1, Francois Potus1, Virginie Tanguay1, Mylène Vaillancourt1, ÈveTremblay1, Sandra Breuils-Bonnet1, Steeve Provencher1 and Sébastien Bonnet1. Role for RUNX2/HDAC6Axis in Pulmonary Arterial Hypertension. Experimental Biology,Abstract

Page 8: Mr. Francois Potus Degrees Recognitionsdeptmed.queensu.ca/assets/Research/Archer Research/Francois Potus... · DRAFT Mr. Francois Potus 1 This is a draft version only. Do not submit

DRAFTMr. Francois Potus

8

39. Jerome Vinck1, Gregoire Ruffenach1, François Potus1, Breuils-Bonnet Sandra1, Steeve Provencher1and Sebastien Bonnet1. miR-223 a new signaling hub accounting for DNA damage signaling and STAT3activation in pulmonary arterial hypertension. Experimental Biology,Abstract

40. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay È, Breuils-Bonnet S, Ribeiro F, Porlier A, MaltaisF, Bonnet S, Provencher S.miR-126 downregulation in skeletal muscle decrease angiogenesisthroughVEGF pathway and contributing to exercise intolerancein pulmonary arterial hypertension. North AmericanVascular Biology Organization (NAVBO),Abstract

41. Grégoire Ruffenach 1*, Sophie Chabot 1*, Virginie F. Tanguay 1, Audrey Courboulin 2, Olivier Boucherat1, Francois Potus 1, Jolyane Meloche 1, Aude Pflieger 1, Sandra Breuils-Bonnet 1, Valérie Nadeau 1,Renée Paradis 1, Eve Tremblay 1, Barbara Girerd 2, Aurélie Hautefort 2, David Montani 2, Elie Fadel2, Peter Dorfmuller 2, Marc Humbert 2, Frédéric Perros 1,2, Roxane Paulin 1, Steeve Provencher 1‡,and Sébastien Bonnet. miR204/RUNX2 axis regulates HIF-1{alpha} activation in pulmonary arterialhypertension. Experimental Biology,Abstract

42. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay È, Breuils-Bonnet S, Ribeiro F, Porlier A, MaltaisF, Bonnet S, Provencher S.miR-126 Dependent Decrease of Skeletal Muscle Microcirculation Contribute toExercise Intolerance in Pulmonary Arterial Hypertension.Experimental Biology,Abstract

43. Potus F; Ranchoux B; Provencher S; Bonnet S.Metabolic Syndrome Exacerbates Pulmonary Hypertensionin Heart Failurewith Preserved Ejection Fraction. American thoracic society International Conference(2016),Conference Date: 2016/5AbstractRefereed?: Yes

44. Francois Potus, Colin Graydon, Wong Ryan, Evangelos Michelakis, Steeve Provencher and SébastienBonnet. miR-126 at the dawn of angiogenic defect seen in PAH right ventricular failure.ExperimentalBiology,Conference Date: 2015/4AbstractRefereed?: Yes, Invited?: No

45. Francois Potus, Gregoire Ruffenach, Steeve Provencher and Sébastien Bonnet. Emerging role ofepigenetic in pulmonary arterial hypertension right ventricular failure. Experimental Biology,Conference Date: 2015/4AbstractRefereed?: Yes, Invited?: No

46. francois potus, simon Malenfant, Sandra Breuils Bonnet, roxane Paulin, Pasquale Ferrero, Evangelosmichelakis, Steeve Provencher, Sébastien Bonnet. Abstract 9518: Role for Mir-126 in Right VentricleFailure in Pulmonary Arterial Hypertension. American Heart Association,Conference Date: 2014/11AbstractRefereed?: Yes

Presentations

1. (2017). Development of new pre-clinical model of pulmonary hypertension associated with left heartdisease.PVRI (pulmonary vascular research institute) 11th annual world congress, United StatesMain Audience: ResearcherInvited?: No

Page 9: Mr. Francois Potus Degrees Recognitionsdeptmed.queensu.ca/assets/Research/Archer Research/Francois Potus... · DRAFT Mr. Francois Potus 1 This is a draft version only. Do not submit

DRAFTMr. Francois Potus

9

2. (2016). Metabolic Syndrome Exacerbates Pulmonary Hypertension in Heart Failure with Preserved EjectionFraction. American thoracic society International Conference, United StatesMain Audience: Knowledge User

3. (2016). Angiogenesis and right ventricle in PAH. interminational meeting of American Heart Association,United StatesMain Audience: ResearcherInvited?: Yes

4. (2016). miR-126 improves angiogenic defect observed in pulmonary arteriel hypertension. PVRI 10thAnnual World Congress, ItalyMain Audience: Knowledge User

5. (2016). Macitentan and angiogenesis: New hope in pulmonary arterial hypertension. PVRI 10th AnnualWorld Congress, ItalyMain Audience: Knowledge User

Student/Postdoctoral Supervision

Bachelor’s [n=5]2015/10 - 2016/1Academic Advisor

Yuliya Badayeva, University of British ColumbiaPresent Position: Student

2015/2 - 2015/7Academic Advisor

Ryan Wong, University of British ColumbiaPresent Position: student master degrees

2014/9 - 2015/1Academic Advisor

Ian Johnson, university of British ColumbiaPresent Position: Student (Medical school)

2014/1 - 2014/2Academic Advisor

Geneviève Paquet, université LavalPresent Position: student

2013/2 - 2013/6Academic Advisor

Colin Graydon, University of British ColumbiaPresent Position: student

Master’s non-Thesis [n=1]2013/9 - 2014/6Academic Advisor

Camille Augan, université de PoitierPresent Position: Student (Medical school)